Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Openn accelerates US growth initiatives with equity Options to listings giant
    • News

    Openn accelerates US growth initiatives with equity Options to listings giant

    In an attempt to accelerate their growth in the lucrative US real estate market, property tech company Openn Negotiation (ASX: OPN) has entered into an equity partnership with leading US listings company Triangle MLS to access their 16,000 realtor members. The agreement is centred around 1 million unlisted Options in Openn whereby Triangle can purchase

    Read More
    Public
  • Melbournian zooming around in semi-automatic signals the return of F1
    • Satire

    Melbournian zooming around in semi-automatic signals the return of F1

    For three years, residents of Albert Park have been able to enjoy the tranquility of urban lifestyle in peace but that has been put on hold this week as Melbournians have been cruising around, revving their engines and switching their humble Prius into semi-automatic mode.  That can only mean one thing – the return of

    Read More
    Public
  • Hostile takeover looming as stakes intensify in Virtus Health IVF bidding war
    • News

    Hostile takeover looming as stakes intensify in Virtus Health IVF bidding war

    If you didn’t already know, there is a crazy amount of money to be made by IVF operators in Australia in the years to come which is the underlying principle behind a corporate tug-of-war in a bid to acquire IVF company Virtus Health (ASX: VRT) which has intensified again with the latest offer proposal from

    Read More
    Public
  • Fed’s Interest Rate expectation policy and yield curve inversion
    • Opinion

    Fed’s Interest Rate expectation policy and yield curve inversion

    The market doesn’t like surprises, and the Federal Reserve is not going to give any. The Federal Reserve has moved to clearly signal interest rate policy, lest the market has any panic with unexpected moves. The current Fed Fund rate of .30% does not reflect their intentions going into the future. Some believe that a

    Read More
    Public
  • Un-Z1P your pants and dip into this
    • Opinion

    Un-Z1P your pants and dip into this

    There has been a monumental shift within the buy now, pay later scene with companies consolidating in a recent blitz of mergers and acquisitions. Confidence in this sector has been diminishing as big players like Z1P (ASX: Z1P) have come back to earth, falling as much as 90% since their all-time highs. Following the Block

    Read More
    Public
  • A signal of more to come? Crowd Media inks 2-year deal with conversational AI client
    • News

    A signal of more to come? Crowd Media inks 2-year deal with conversational AI client

    Try before you buy. It’s a time-honoured sales tactic that has worked for the most successful companies in history and artificial intelligence company Crowd Media (ASX: CM8) can join that list having converted a Proof Of Concept of their AI platform into a 2 year contract. Healthcare company PangeaMed will one day lay claim to

    Read More
    Public
  • «
  • ‹
  • 391
  • 392
  • 393
  • 394
  • 395
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.